Literature DB >> 12063897

Use of drug manufacturers' patient assistance programs by safety net providers.

Katheryne Richardson1, Lorne E Basskin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12063897     DOI： 10.1093/ajhp/59.11.1105

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  3 in total

Review 1.  What is the evidence for pharmaceutical patient assistance programs? A systematic review.

Authors:  Tisha M Felder; Nynikka R Palmer; Lincy S Lal; Patricia Dolan Mullen
Journal:  J Health Care Poor Underserved       Date:  2011-02

2.  Utilization of Pharmaceutical Patient and Prescription Assistance Programs via a Pharmacy Department Patient Assistance Program for Indigent Cancer Patients.

Authors:  Limin Gao; Jivin Joseph; Marcelle Santoro-Levy; Alan S Multz; Vladimir K Gotlieb
Journal:  Hosp Pharm       Date:  2016-07

3.  Medication assistance programs: do all in need benefit equally?

Authors:  Maria Pisu; Katie Crenshaw; Ellen Funkhouser; Midge Ray; Catarina I Kiefe; Kenneth Saag; Cynthia LaCivita; Jeroan J Allison
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.